IV inodilators for the management of acute and advanced heart failure: why, when and how?

Dr John Parissis presents the key take-home messages from the symposium. These include the rationale for utilisation of levosimendan in acute heart failure (symptoms and haemodynamics, peripheral organ effects) and advanced heart failure (quality of life, reduced hospital admission and re-admission), timing (earlier use to avoid further organ injury) and administration.

 

ESC 2019 resources


Login/ Register Maximise Minimise